Glicana 100 mg Packaging
Click to zoom
DGDA Registration: DGDA Certified
Authentic Manufacturer Packaging
Tablet 100 mg Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors

Glicana

Manufactured by: Incepta Pharmaceuticals Ltd.
Retail Price (MRP)
৳60.00 / unit
Pack: ৳600.00 (1 x 10) Strip: ৳600.00
Prescription Course & Cost Estimator
Estimate required Tablet count, strips, and pharmacy bill
Daily Dose:
/day
Duration:
days
Total Required Quantity 14 Tablets ~2 Strips (of 10 Tablets)
Estimated Prescription Bill ৳840.00 ৳1200.00 for 2 full strips
View Basket 🛒

Cheaper & Alternative Brands (100 mg)

Same active generic (Canagliflozin Hemihydrate), same form (Tablet), exact same strength (100 mg)

Clinical Prescribing Information

Medical monograph and safety information for healthcare professionals & patients.
📋

Indications & Clinical Uses

Canaglif is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Dosage & Administration

The recommended starting dose is 100 mg once daily, taken before the first meal of the day. Dose can be increased to 300 mg once daily who have CrCl>60 ml/min or who requires additional glycemic control. No dose adjustment is required for mild renal impairment. For moderate renal impairment (CrCl 45-60 ml/min) Canagliflozin 100 mg is recommended.

⚠️

Contraindications

History of serious hypersensitivity reaction to Canagliflozin, severe renal impairment, End Stage Renal Disease (ESRD), or on dialysis patients.

⚡

Side Effects & Adverse Reactions

The most common adverse reactions of Canaglif are female genital mycotic infections, urinary tract infection and increased urination. Other side effects of Canaglif include low blood pressure, increases potassium blood levels (hyperkalemia), low blood glucose and increases Low-Density Lipoprotein (LDL-C).

🛡️

Warnings & Precautions

Not for the treatment of type 1 diabetes mellitus or diabetic ketoacidosis.

🔬

Pharmacology & Mechanism of Action

Canagliflozin is an inhibitor of subtype-2 sodium-glucose co-transport protein (SGLT2), which is responsible for at least 90% of the glucose reabsorption in the kidney. Blocking this transporter reduces the reabsorption of glucose from renal tubules, leading to more excretion of glucose in urine.

Medical Disclaimer: The clinical monographs, pricing, and formulations on BD Medi Price are compiled for reference and informational purposes only. Always seek the advice of a registered physician regarding any medical treatment.
Glicana ৳60.00 / unit
Compare Alternatives
Link copied to clipboard!